National Geographic - November 2, 2022
Betsy Herold, M.D., says that long COVID symptoms that children display—including headaches, mood swings, fatigue, and abdominal pain—may be the result of COVID infection and/or a variety of other causes. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and the Children's Hospital at Montefiore, and the Harold and Muriel Block Chair in Pediatrics at Einstein.
Dr. Herold's ProfileMore coverage on Dr. Herold
The Washington Post - November 1, 2022
Johanna Daily, M.D., M.S., notes the positive results from a study evaluating an antimalarial drug were exciting and that it can potentially play an important role in preventing infection and disease around the world. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.
Additional coverage includes The Associated Press
Dr. Daily's ProfileMore coverage on Dr. Daily
MedPageToday - October 30, 2022
Fourth-year Einstein medical student Nathan Feiertag discusses his metanalysis, presented at the Sexual Medicine Society of North America's annual meeting, that indicated a link between a plant-based diet and a lower risk of prostate cancer.
The New York Times - October 25, 2022
Jill Crandall, M.D., discusses the link between statins and diabetes risk, noting that the risk is modest, but higher, for those who are prediabetic when they begin taking statins to lower their blood cholesterol levels. Dr. Crandall is professor of medicine and the Jacob A. and Jeanne E. Barkey Chair in Medicine at Einstein, and chief of endocrinology at Einstein and Montefiore.
Dr. Crandall's ProfileMore coverage on Dr. Crandall
Time - October 21, 2022
Gabriele de Vos, M.D., M.S., says immunotherapy may not be effective for some people with allergies because it is difficult to develop individual tests—and therefore treatments—to determine the specific causes of a person's allergy. Dr. de Vos is associate professor of medicine at Einstein and an allergist and immunologist at Jacobi Medical Center.
Dr. de Vos' Profile
The Wall Street Journal - October 4, 2022
Kartik Chandran, Ph.D., talks about the need for medical professionals to be ready for future outbreaks of Ebola by working on novel vaccines and drugs that are effective against numerous strains of the virus, rather than only one strain. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology at Einstein.
Additional coverage includes The New York Times and Nature
Dr. Chandran's ProfileMore coverage on Dr. Chandran
Connecticut Public Radio - September 21, 2022
Sofiya Milman, M.D., M.S., discusses the SuperAgers Initiative, a study launching in October 2022 that will investigate genetic and health information to understand the science behind longevity in 10,000 people aged 95 and older in the United States. Dr. Milman is associate professor of medicine and of genetics and is director of human longevity studies at the Institute for Aging Research and an endocrinologist at Montefiore.
Dr. Milman's ProfileMore coverage on Dr. Milman
The New York Times - September 14, 2022
Shelby Freedman Harris, Psy.D., comments on the role of stress in triggering nightmares and suggests having consistent sleep and wake times to help improve the quality and duration of sleep. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein.
Dr. Harris's ProfileMore coverage on Dr. Harris
The New York Times - August 16, 2022
Cristina Gonzalez, M.D., M.Ed., an expert in implicit bias recognition and management, recalls the case of a young Hispanic patient whose caregivers initially doubted his pain level, which could have delayed his treatment and led to life-threatening damage. Dr. Gonzalez is professor of medicine at Einstein and a hospitalist at Montefiore.
Dr. Gonzalez's Profile
STAT News - August 9, 2022
Nir Barzilai, M.D., discusses the challenges of funding a clinical trial to test the effects of the diabetes drug metformin on delaying age-associated diseases like cancer, diabetes, and heart disease. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
NBC News - July 30, 2022
Ulrich Jorde, M.D., says the first HIV-positive to HIV positive heart transplant, performed at Montefiore, is a milestone in the history of organ donation. Dr. Jorde is professor of medicine at Einstein and head of heart failure, cardiac transplantation & mechanical circulatory support and vice chief of the division of cardiology at Montefiore.
Dr. Jorde's Profile
BronxNet - July 27, 2022
Balazs Halmos, M.D., discusses a grant that will enable the Montefiore Einstein Cancer Center to improve lung cancer care for underserved minority patients. Dr. Halmos is professor of medicine at Albert Einstein College of Medicine and associate director of clinical science at the Montefiore Einstein Cancer Center.
Dr. Halmos' ProfileMore coverage on Dr. Halmos
Medscape - July 26, 2022
Robert Grossberg, M.D., comments on an analysis that found certain anti-viral treatments for COVID-19 may help patients avoid hospitalization or death, but notes that the studies were done only in unvaccinated participants and before the Omicron variant emerged. Dr. Grossberg is associate professor of medicine at Einstein and an infectious disease physician at Montefiore.
Dr. Grossberg's Profile
Medscape - July 25, 2022
Matthias Eikermann, M.D., discusses his study that found that patients who identified as Black versus those who identified as white have a higher risk of adverse discharge to a nursing home after surgery. Dr. Eikermann is professor and chair of anesthesiology at Einstein and Montefiore. chair of anesthesiology at Montefiore.
Dr. Eikermann's Profile